Compared with IN (17 out of 27, 62.96% Figure 2f) and ANT (33 out of 100, 33.00% Figure 2g), the proportion of high Versican expression was significantly larger in gastric adenocarcinoma than that in either IN (P=0.004) or ANT (P=0.000; Figure 2h). This evidence concerns the gene VCAN and gastric adenocarcinoma.